← Back to headlines
Mars CEO Appointed to Novo Nordisk Board
The CEO of Mars has been appointed to a board role at Novo Nordisk, a key supplier of GLP-1 drugs.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
